Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease

Published: June 16, 2014

  • Under-treatment and under-testing in women lead to increased complications and to higher rate of case fatalities.
  • Atherosclerotic coronary artery disease (CAD) continues to be underrecognized and underdiagnosed in women, contributing to the high mortality.
  • This statement provides modern evidence to assist in identifying the appropriate female candidates for diagnostic testing.